Cardiovascular an Echocardiographic Assessment in Hypertension During Pregnancy

Completed

• Conditions: Pregnancy

• Registration Number: NCT01068002
• Lead Sponsor: HaEmek Medical Center, Israel

Brief Summary

Cardiovascular \& echocardiographic assessment in pregnant women with hypertension during their pregnancy in comparison to Pregnant normotensive women.

Detailed Description

Cardiovascular \& echocardiographic assessment in pregnant women with hypertension during their pregnancy in comparison to Pregnant normotensive women. Also,comparing echocardiographic parameters in hypertensive pregnant women being treated with either alfa methyl dopa or labetolol.

Study Timeline

• Study Start: 2009-06
• Study First Submitted: 2010-02-11
• Study First Submitted QC: 2010-02-11
• Study First Posted: 2010-02-12
• Primary Completion: 2012-06
• Study Completion: 2012-09
• Status Verified: 2020-02
• Last Update Submitted: 2020-02-11
• Last Update Posted: 2020-02-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 80

Inclusion Criteria

• hypertension during pregnancy: Chronic or pregnancy induced

Exclusion Criteria

• Inability to sign informed consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hypertension impact on cardiovascular echocardiographic parameters and obstetric parameters in pregnant women with or without treatment	1 year

Secondary Outcome Measures

Name	Time	Method
Primary outcome, Impact of alfa methyl dopa and labetolol on cardiovascular parameters in pregnant women	1 Year

Trial Locations

Locations (1)

Ha'Emek Medical Center; 🇮🇱 Afula, Israel